Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
| $981K | ﹤0.01% |
10,155
-81,147
| -89% | -$7.25M |
|
3902
Stereotaxis
STXS
$135M
| $978K | ﹤0.01% |
219,351
+61,293
| +39% | +$248K |
|
|
LOVE
3903
LoveSac
LOVE
$252M
| $976K | ﹤0.01% |
37,200
-23,977
| -39% | -$365K |
|
|
MRNS
3904
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $974K | ﹤0.01% |
95,823
+80,950
| +544% | +$745K |
|
|
HTT
3905
High Templar Tech Ltd
HTT
$385M
| $973K | ﹤0.01% |
572,222
+113,161
| +25% | +$187K |
|
3906
Modine Manufacturing
MOD
$10.2B
| $972K | ﹤0.01% |
176,074
+63,835
| +57% | +$293K |
|
3907
Quanterix
QTRX
$180M
| $970K | ﹤0.01% |
35,435
+3,930
| +12% | +$99.3K |
|
3908
CALL
Acadia Pharmaceuticals
ACAD
$4.9B
| $969K | ﹤0.01% |
20,000
-54,500
| -73% | -$2.62M |
|
3909
Tredegar Corp
TG
$270M
| $969K | ﹤0.01% |
62,905
-53,064
| -46% | -$822K |
|
3910
Digi International
DGII
$3.13B
| $965K | ﹤0.01% |
82,804
-51,199
| -38% | -$547K |
|
3911
iShares MSCI Australia ETF
EWA
$1.44B
| $964K | ﹤0.01% |
50,000
| – | – |
|
3912
Progyny
PGNY
$2.37B
| $964K | ﹤0.01% |
37,327
+25,996
| +229% | +$597K |
|
3913
PUT
Ryder
R
$10.1B
| $964K | ﹤0.01% |
25,700
| – | – |
|
3914
iShares JPMorgan EM Corporate Bond ETF
CEMB
$405M
| $962K | ﹤0.01% |
+18,990
| New | +$924K |
|
3915
Republic Bancorp
RBCAA
$1.96B
| $961K | ﹤0.01% |
29,379
-578
| -2% | -$18.3K |
|
3916
Ranpak Holdings
PACK
$466M
| $960K | ﹤0.01% |
129,044
-72,865
| -36% | -$536K |
|
|
FSB
3917
DELISTED
Franklin Financial Network, Inc.
FSB
| $954K | ﹤0.01% |
37,030
-31,531
| -46% | -$738K |
|
3918
SunCoke Energy
SXC
$815M
| $953K | ﹤0.01% |
321,742
-121,142
| -27% | -$387K |
|
|
MTSC
3919
DELISTED
MTS Systems Corp
MTSC
| $953K | ﹤0.01% |
54,161
-39,303
| -42% | -$726K |
|
3920
RPC Inc
RES
$1.31B
| $951K | ﹤0.01% |
308,663
-97,568
| -24% | -$297K |
|
|
MMX
3921
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $950K | ﹤0.01% |
+213,875
| New | +$920K |
|
|
HTBK
3922
DELISTED
Heritage Commerce
HTBK
| $949K | ﹤0.01% |
126,412
+16,929
| +15% | +$133K |
|
|
AMRS
3923
DELISTED
Amyris Inc.
AMRS
| $944K | ﹤0.01% |
220,950
+77,576
| +54% | +$258K |
|
3924
Global Industrial
GIC
$1.51B
| $942K | ﹤0.01% |
45,864
+23,935
| +109% | +$464K |
|
|
GCAP
3925
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $942K | ﹤0.01% |
156,450
+75,810
| +94% | +$467K |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.